By Andrew Silver SHANGHAI/SUZHOU, China (Reuters) – China’s vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, …
Topic:
drugmakers
-
-
By Jason Xue and Tom Westbrook SHANGHAI (Reuters) – A growing number of healthcare companies in China are shelving their initial public offering (IPO) plans as its stock exchanges have …
-
By Patrick Wingrove and Michael Erman (Reuters) – Some of the world’s biggest drugmakers are laying legal groundwork to fight the U.S. plan to negotiate drug prices for its Medicare …
-
FRANKFURT – Global drugmakers are lobbying for wealthy nations to fund a supply mechanism that would secure vaccines for low-income countries without delay in case of a new pandemic, but …
-
– Russian Health Minister Mikhail Murashko on Thursday said the situation with medicines was stable in Russia and that all producers were continuing to work, the RIA news agency reported. …
-
WASHINGTON – The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee …